Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2010 1
2011 2
2012 1
2015 1
2016 5
2017 2
2018 2
2019 2
2020 1
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all The following terms were ignored: %, % The following terms were not found in PubMed: 5BAuthor
Page 1
Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB).
Clarke CE, Patel S, Ives N, Rick CE, Woolley R, Wheatley K, Walker MF, Zhu S, Kandiyali R, Yao G, Sackley CM. Clarke CE, et al. Among authors: zhu s. Health Technol Assess. 2016 Aug;20(63):1-96. doi: 10.3310/hta20630. Health Technol Assess. 2016. PMID: 27580669 Free PMC article. Clinical Trial.
Secondary outcomes were health-related quality of life [Parkinson's Disease Questionnaire-39 (PDQ-39); European Quality of Life-5 Dimensions (EQ-5D)], adverse events, resource use and carer quality of life (Short Form questionnaire-12 items). ...Repeated measures analysis …
Secondary outcomes were health-related quality of life [Parkinson's Disease Questionnaire-39 (PDQ-39); European Quality of Life-5 Dimensions …
A randomised controlled study of the effectiveness of breathing retraining exercises taught by a physiotherapist either by instructional DVD or in face-to-face sessions in the management of asthma in adults.
Thomas M, Bruton A, Little P, Holgate S, Lee A, Yardley L, George S, Raftery J, Versnel J, Price D, Pavord I, Djukanovic R, Moore M, Kirby S, Yao G, Zhu S, Arden-Close E, Thiruvothiyur M, Webley F, Stafford-Watson M, Dixon E, Taylor L. Thomas M, et al. Among authors: zhu s. Health Technol Assess. 2017 Sep;21(53):1-162. doi: 10.3310/hta21530. Health Technol Assess. 2017. PMID: 28944752 Free PMC article. Clinical Trial.
Secondary outcomes included asthma symptom control [Asthma Control Questionnaire (ACQ)], psychological state [Hospital Anxiety and Depression Scale (HADS)], hyperventilation symptoms (Nijmegen questionnaire), generic QoL [EuroQol-5 Dimensions (EQ-5D)], assessments of airwa …
Secondary outcomes included asthma symptom control [Asthma Control Questionnaire (ACQ)], psychological state [Hospital Anxiety and Depressio …
Adjunct rasagiline to treat Parkinson's disease with motor fluctuations: a randomized, double-blind study in China.
Zhang Z, Shao M, Chen S, Liu C, Peng R, Li Y, Wang J, Zhu S, Qu Q, Zhang X, Chen H, Sun X, Wang Y, Sun S, Zhang B, Li J, Pan X, Zhao G. Zhang Z, et al. Among authors: zhu s. Transl Neurodegener. 2018 Jun 30;7:14. doi: 10.1186/s40035-018-0119-7. eCollection 2018. Transl Neurodegener. 2018. PMID: 29988514 Free PMC article.
Secondary endpoints were Clinical Global Impressions - Improvement (CGI-I), and change in Unified Parkinson's Disease Rating Scale (UPDRS) Activities of daily living (ADL) and Motor scores. Patient well-being (EQ-5D), and the frequency of adverse events were also assessed. …
Secondary endpoints were Clinical Global Impressions - Improvement (CGI-I), and change in Unified Parkinson's Disease Rating Scale (UPDRS) A …
Patient-reported outcome measures for monitoring primary care patients with depression (PROMDEP): study protocol for a randomised controlled trial.
Kendrick T, Moore M, Leydon G, Stuart B, Geraghty AWA, Yao G, Lewis G, Griffiths G, May C, Dewar-Haggart R, Williams S, Zhu S, Dowrick C. Kendrick T, et al. Among authors: zhu s. Trials. 2020 May 29;21(1):441. doi: 10.1186/s13063-020-04344-9. Trials. 2020. PMID: 32471492 Free PMC article.
Secondary outcomes include BDI-II at 26 weeks, changes in drug treatments and referrals, social functioning (Work & Social Adjustment Scale) and quality of life (EQ-5D) at 12 and 26 weeks, service use over 26 weeks (modified Client Services Receipt Inventory) to calcul …
Secondary outcomes include BDI-II at 26 weeks, changes in drug treatments and referrals, social functioning (Work & Social Adjustment Sc …
Efficacy and safety of rasagiline in Chinese patients with early Parkinson's disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study.
Zhang Z, Wang J, Chen S, Liu C, Zhang B, Peng R, Sun S, Sun X, Zhao G, Qu Q, Li Y, Zhu S, Pan X, Shao M, Wang Y. Zhang Z, et al. Among authors: zhu s. Transl Neurodegener. 2018 Dec 6;7:32. doi: 10.1186/s40035-018-0137-5. eCollection 2018. Transl Neurodegener. 2018. PMID: 30534374 Free PMC article.
Health status was assessed with the PD Questionnaire (PDQ)-39 and EuroQol-Five-Dimension (EQ-5D) questionnaire. Safety profile was collected until 30 weeks after randomization. ...An improvement trend was observed in the active treatment group for the subscales evaluation …
Health status was assessed with the PD Questionnaire (PDQ)-39 and EuroQol-Five-Dimension (EQ-5D) questionnaire. Safety profile was co …
Analgesic effect and possible mechanism of SCH772984 intrathecal injection on rats with bone cancer pain.
Bian J, Zhu S, Ma W, Li C, Ashraf MA. Bian J, et al. Among authors: zhu s. Saudi Pharm J. 2016 May;24(3):354-62. doi: 10.1016/j.jsps.2016.04.017. Epub 2016 Apr 26. Saudi Pharm J. 2016. PMID: 27275127 Free PMC article.
Establish a bone cancer pain model after putting the intrathecal tube 5d and determine the rats' mechanical withdrawal threshold (MWT) after tube 5d; 40 SD rats with intrathecal tube back 5d were randomly divided into 5 groups. ...
Establish a bone cancer pain model after putting the intrathecal tube 5d and determine the rats' mechanical withdrawal threshold (MWT …
Patient-reported outcome measures for monitoring primary care patients with depression: PROMDEP feasibility randomised trial.
Kendrick T, Stuart B, Leydon GM, Geraghty AW, Yao L, Ryves R, Williams S, Zhu S, Dowrick C, Lewis G, Moore M. Kendrick T, et al. Among authors: zhu s. BMJ Open. 2017 Mar 30;7(3):e015266. doi: 10.1136/bmjopen-2016-015266. BMJ Open. 2017. PMID: 28363932 Free PMC article. Clinical Trial.
SECONDARY OUTCOME MEASURES: Work and Social Adjustment Scale (WSAS), EuroQol Five-item, Five-level (EQ-5D-5L) Scale for quality of life, modified Client Service Receipt Inventory for costs, Medical Informant Satisfaction Scale (MISS), qualitative interviews with 14 patient …
SECONDARY OUTCOME MEASURES: Work and Social Adjustment Scale (WSAS), EuroQol Five-item, Five-level (EQ-5D-5L) Scale for quality of li …
19 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page